Eton Pharmaceuticals, Inc. — Director's Dealing 2018

Nov 13, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Eton Pharmaceuticals, Inc. (ETON)
CIK: 0001710340
Period of Report: 2018-11-09

Reporting Person: RIEDEL NORBERT G (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	54745	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Units	$0.00		Common Stock (25000)		Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of ETON common stock. The restricted stock units vested in four
equal quarterly installments at the end of each quarter and were fully vested on June 30, 2018. Per the terms of the RSU award agreement, the
shares will be delivered to the reporting person 30 days after retiring from service as a director.